Back to News
Market Impact: 0.2
CAPR 5-DAY DEADLINE: Capricor Investors Have Opportunity to Lead Class Action
Source: businesswire.com
Legal & LitigationHealthcare & Biotech
Hagens Berman is investigating claims tied to a class-action complaint filed on behalf of investors against Capricor Therapeutics. The notice signals potential securities-litigation risk for CAPR, though no allegations, damages, or case-specific financial impact were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
CAPR-0.80
More News
- Street Calls of The Week
- Paraguay’s ousted president charged over banking scandal
- argenx reports positive phase 3 data for autoimmune myositis drug
- U.S. intelligence memo ties Nvidia’s Huang to alleged Chinese spy, FT reports
- Why the prognosis for healthcare stocks is uncertain ahead of Congress’ new makeup
- What Walker & Dunlop (WD) Said on Its Q3 Earnings Call